Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Matthew Shea initiated coverage on Alignment Healthcare Inc (NASDAQ:ALHC) with a Hold rating. Alignment Healthcare closed at $8.05 on Tuesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Kristen Kluska initiated coverage on Spero Therapeutics Inc (NASDAQ:SPRO) with an Overweight rating and announced a price target of $6. Spero Therapeutics shares closed at $1.14 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Matthew Keller initiated coverage on Lakewood-amedex Biotherapeutics Inc (NASDAQ:LABT) with a Buy rating and announced a price target of $3. Lakewood-Amedex closed at $0.29 on Tuesday. See how other analysts view this stock.
- Needham analyst Matthew Shea initiated coverage on Clover Health Investments Corp (NASDAQ:CLOV) with a Buy rating and announced a price target of $6. Clover Health Investments shares closed at $4.63 on Tuesday. See how other analysts view this stock.
- Susquehanna analyst Joseph Stauff initiated coverage on MSG Rangers (NYSE:MSGR) with a Positive rating and announced a price target of $228. MSG Rangers closed at $177.61 on Monday. See how other analysts view this stock.
Considering buying SPRO stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments